TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T74363	Urokinase plasminogen activator surface receptor	B38XQK	3-[(3-Bromo-4-hydroxy-6,7-dimethyl-9,10-dioxoanthracen-1-yl)amino]benzoic acid	Investigative	71450599	C23H16BrNO5	466.3	CC1=CC2=C(C=C1C)C(=O)C3=C(C2=O)C(=CC(=C3O)Br)NC4=CC=CC(=C4)C(=O)O	IC50 = 67000 nM	Poor binder
T74363	Urokinase plasminogen activator surface receptor	B6OY7M	N-{3-[3-(Ethoxycarbonyl)piperidin-1-yl]-6-oxo-6H-anthra[1,9-cd]isoxazol-5-yl}-beta-alanine	Investigative	15994611	C25H25N3O6	463.5	CCOC(=O)C1CCCN(C1)C2=CC(=C3C4=C(C5=CC=CC=C5C3=O)ON=C24)NCCC(=O)O	IC50 = 51000 nM	Poor binder
T74363	Urokinase plasminogen activator surface receptor	B9CM2B	Methyl 3-[[12-(azepan-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]benzoate	Investigative	68295193	C28H25N3O4	467.5	COC(=O)C1=CC(=CC=C1)NC2=C3C4=C(C5=CC=CC=C5C3=O)ON=C4C(=C2)N6CCCCCC6	IC50 ~ 100000 nM	Poor binder
T74363	Urokinase plasminogen activator surface receptor	B9THV7	3-[(3-Bromo-4-hydroxy-6-methyl-9,10-dioxoanthracen-1-yl)amino]benzoic acid	Investigative	71457753	C22H14BrNO5	452.3	CC1=CC2=C(C=C1)C(=O)C3=C(C2=O)C(=C(C=C3NC4=CC=CC(=C4)C(=O)O)Br)O	IC50 = 146000 nM	Poor binder
T74363	Urokinase plasminogen activator surface receptor	BF83TH	4-{[6-Oxo-3-(4-oxopiperidin-1-yl)-6H-anthra[1,9-cd]isoxazol-5-yl]amino}benzoic acid	Investigative	5052527	C26H19N3O5	453.4	C1CN(CCC1=O)C2=CC(=C3C4=C(C5=CC=CC=C5C3=O)ON=C24)NC6=CC=C(C=C6)C(=O)O	IC50 ~ 100000 nM	Poor binder